• Nano-X Imaging revenue rose 37% year over year to USD 4.2 million, boosted by Nanox Health IT consolidation, which added USD 0.9 million.
• GAAP net loss widened to USD 55.5 million, reflecting a USD 40.7 million intangible-asset impairment tied to the AI solutions unit.
• Adjusted EBITDA loss increased to USD 11.3 million from the year-ago quarter.
• Cash and cash equivalents fell to USD 31.4 million at June 30, 2026; it raised USD 8.5 million post-quarter-end.
• Commercial updates included first patient scans at the initial Nanox Imaging Network site in Philadelphia, insurer reimbursements for scans, and 10 U.S. distribution partners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nano-X Imaging Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609090803PRIMZONEFULLFEED9823717) on September 09, 2026, and is solely responsible for the information contained therein.